Cryoglobulins as indicators of upregulated immune response in schizophrenia

Clinical Biochemistry

Volumn 41, Issue 6, 2008, Pages 355-360

  Boyajyan, Anna ^a   Khoyetsyan, Aren ^a   Tsakanova, Gohar ^a   Sim, Robert B ^b  

^a H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Complement proteins; Cryoglobulins; Immunoglobulins; Schizophrenic patients

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CRYOGLOBULIN; TYPE III CRYOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; SCHIZOPHRENIA; UPREGULATION;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; COMPLEMENT C1Q; COMPLEMENT C3; CRYOGLOBULINS; FEMALE; HUMANS; IMMUNE SYSTEM; MIDDLE AGED; SCHIZOPHRENIA;

EID: 40849097773     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.11.014     Document Type: Article

References (55)

1. Riedel M., Spellmann I., Schwarz M.J., et al. Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 41 1-2 (2007) 3-7
2. Kipnis J., Cardon M., Strous R.D., and Schwartz M. Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia?. Trends Mol Med 12 3 (2006) 107-112
3. Hanson D.R., and Gottesman I.I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 6 7 (2005) 1-17
4. Jones A.L., Mowry B.J., Pender M.P., and Greer J.M. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?. Immunol Cell Biol 83 1 (2005) 9-17
5. Rothermundt M., Arolt V., and Bayer T.A. Review of immunological and immunophatological findings in schizophrenia. Brain Behav Immunol 15 4 (2001) 319-339
6. Müller N., Riedel M., Ackenheil M., and Schwarz M.J. Cellular and humoral immune system in schizophrenia: a conceptual re-evalution. World J Biol Psychiatry 1 4 (2000) 173-179
7. Tedeschi A., Barate C., Minola E., and Morra E. Cryoglobulinemia. Blood Rev 21 4 (2007) 183-192
8. Hilgard P., Treichel U., Dries V., Dienes H.P., and Gerken G. Cryoglobulin-associated uptake of hepatitis C virus into human hepatocytes. Hepatogastroenterology 52 65 (2005) 1534-1540
9. Mohammed K., and Rehman H.U. Cryoglobulinaemia. Acta Med Austriaca 30 3 (2003) 65-68
10. Ferri C., Zignego A.L., and Pileri S.A. Cryoglobulins. J Clin Pathol 55 1 (2002) 4-13
11. Newkirk M.M. Rheumatoid factors: host resistance or autoimmunity?. Clin Immunol 104 1 (2002) 1-13
12. Dispenzieri A. Symptomatic cryoglobulinemia. Curr Treat Options Oncol 1 2 (2000) 105-118
13. Weiner S.M., Prasauskas V., Lebrecht D., Weber S., Peter H.H., and Vaith P. Occurrence of C-reactive protein in cryoglobulins. Clin Exp Immunol 125 2 (2001) 316-322
14. Kallemuchikkal U., and Gorevic P.D. Evaluation of cryoglobulins. Arch Pathol Lab Med 123 2 (1998) 119-125
15. Mayilyan K.R., Arnold J.N., Presanis J.S., Soghoyan A.F., and Sim R.B. Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. Neurosci Lett 404 3 (2006) 336-341
16. Hakobyan S., Boyajyan A., and Sim R. Classical pathway complement activity in schizophrenia. Neurosci Lett 374 1 (2005) 35-37
17. Schroers R., Nothen M.M., Rietschel M., et al. Investigation of complement C4B deficiency in schizophrenia. Hum Hered 47 5 (1997) 279-282
18. Fananas L., Moral P., Panadero M.A., and Bertranpetit J. Complement genetic markers in schizophrenia: C3, BF and C6 polymorphisms. Hum Hered 42 3 (1992) 162-167
19. Musset L., Diemert M.C., and Taibi F. Characterization of cryoglobulins by immunoblotting. Clin Chem 38 6 (1992) 798-802
20. Hardin J.A. Cryoprecipitogogue from normal serum: mechanism for cryoprecipitation of immune complexes. Proc Natl Acad Sci U S A 78 7 (1981) 4562-4565
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
22. Johnstone A., and Thorpe R. Purification of immunoglobulins, constituent chains and fragments. Chapter 3. Immunochemistry in Practice. 2nd Edition (1987), Blackwell Scientific publications, Oxford, UK 48-85
23. Sim R.B., Day A.J., Moffatt B.E., and Fontaine M. Complement factor I and its cofactors in the regulation of the complement system convertases. Methods Enzymol 223 (1993) 13-35
24. Dodds A.W. Small-scale preparation of complement components C3 and C4. Methods Enzymol 223 (1993) 46-61
25. Brouet J.O., Clauvel J.P., Danon F., Klein M., and Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57 5 (1974) 775-788
26. Oliver M., Coton T., Ragot C., Chianea D., Moalic J.L., and Debonne J.M. Cryoglobulins: detection, type determination and quantitation. A study of healthy subjects and patients with chronic hepatitis C. Ann Biol Clin (Paris) 63 1 (2005) 59-65
27. Maire M.A., Mittey M., and Lambert P.H. The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions. Autoimmunity 2 2 (1989) 155-164
28. Beratis S., Gabriel J., and Hoidas S. Gender differences in the frequency of schizophrenic subtypes in unselected hospitalized patients. Schizophr Res 23 3 (1997) 239-244
29. Beratis S., Gabriel J., and Hoidas S. Age at onset in subtypes of schizophrenic disorders. Schizophr Bull 20 2 (1994) 287-296
30. Bassett A.S., Chow E.W., and Weksberg R. Chromosomal abnormalities and schizophrenia. Am J Med Genet 97 1 (2000) 45-51
31. Kumra S., Wiggs E., Krasnewich D., et al. Brief Report: association of sex chromosome anomalies with childhood-onset psychotic disorders. J Am Acad Child Adolesc Psych 37 3 (1998) 292-296
32. DeLisi L.E., Friedrich U., Wahlstrom J., et al. Schizophrenia and sex chromosome abnormalities. Schizophr Bull 20 3 (1994) 495-505
33. Seeman M.V., and Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 16 2 (1990) 185-194
34. Silman A.J., and Pearson J.E. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4 3 (2002) 265-272
35. Arniaud D., Mattei J.P., Boyer J., and Roux H. Sex hormones in spondylarthropathies. A study in 57 patients. Rev Rhum Engl Ed 65 1 (1998) 21-26
36. Giglio T., Imro M.A., Filaci G., et al. Immune cell circulating subsets are affected by gonadal function. Life Sci 54 18 (1994) 1305-1312
37. Nauta A.J., Roos A., and Daha M.R. A Regulatory role for complement in innate immunity and autoimmunity. Int Arch Allergy Immunol 134 4 (2004) 310-323
38. Cole D.S., and Morgan B.P. Beyond lysis: how complement influences cell fate. Clin Sci 104 5 (2003) 455-466
39. Sim R.B., and Laich A. Serine proteases of the complement system. Rev Biochem Soc Trans 28 5 (2000) 545-550
40. Arnold S.E., Talbot K., and Hahn C.G. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 147 (2005) 319-345
41. Rapoport J.L., Addington A.M., and Frangou S. Ppsych MRC. The neurodevelopmental model of schizophrenia. Mol Psychiatry 10 (2005) 434-449
42. Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25 (2002) 409-432
43. Jarskog L.F., Glantz L.A., Gilmore J.H., and Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 5 (2005) 846-858
44. Jarskog L.F., Selinger E.S., Lieberman J.A., and Gilmore J.H. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry 161 1 (2004) 109-115
45. Berger G.E., Wood S., and McGorry P.D. Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacol Bull 37 2 (2003) 79-101
46. Kozlovsky N., Belmaker R.H., and Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol 12 1 (2002) 13-25
47. Catts V.S., and Catts S.V. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?. Schizophr Res 41 3 (2000) 405-415
48. Lewis D.A., and Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28 2 (2000) 325-334
49. Margolis R.L., Chuang D.M., and Post R.M. Programmed cell death: implications for neuropsychiatric disorders. Biol Psychiatry 35 12 (1994) 946-956
50. Verbovetski I., Bychkov H., Trahtemberg U., et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 196 12 (2002) 1553-1561
51. Strous R.D., and Shoenfeld Y. Revisiting old ghosts: prenatal viral exposure and schizophrenia. IMAJ 7 (2005) 43--45
52. Strous R.D., and Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27 (2006) 71-80
53. Ferri C., and Mascia M.T. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18 1 (2006) 54-63
54. Hellmich B., Lamprecht P., Aries P.M., and Gross W.L. Early diagnosis of vasculitides. Z Rheumatol 64 8 (2005) 538-546
55. Mathsson L., Tejde A., Carlson K., et al. Cryoglobulin-induced cytokine production via FcgammaRIIa: inverse effects of complement blockade on the production of TNF-alpha and IL-10. Implications for the growth of malignant B-cell clones. Br J Haematol 129 6 (2005) 830-838